Skip to main content

Research Repository

Advanced Search

Phase I and Pharmacodynamic Study of Fludarabine, Carboplatin, and Topotecan in Patients with Relapsed, Refractory or High Risk Acute Leukemia and Advanced Myelodysplastic Syndromes.

Cooper, B.W; Veal, G.J; Radivoyevitch, T; Tilby, M.J; Meyerson , H.J; Lazarus, H.M; Koc , O.N; Creger, R.J; Pearson, D.G; Nowell , G.M; Gosky, D; Ingalls, S.T; Hoppel, C.L; Gerson, S.L

Authors

B.W Cooper

G.J Veal

T Radivoyevitch

M.J Tilby

H.J Meyerson

H.M Lazarus

O.N Koc

R.J Creger

D.G Pearson

D Gosky

S.T Ingalls

C.L Hoppel

S.L Gerson



Citation

Cooper, B., Veal, G., Radivoyevitch, T., Tilby, M., Meyerson, H., Lazarus, H., …Gerson, S. (2004). Phase I and Pharmacodynamic Study of Fludarabine, Carboplatin, and Topotecan in Patients with Relapsed, Refractory or High Risk Acute Leukemia and Advanced Myelodysplastic Syndromes. Clinical Cancer Research, 10, 6830-6839

Journal Article Type Article
Publication Date 2004
Journal Clinical Cancer Research
Print ISSN 1078-0432
Publisher American Association for Cancer Research
Volume 10
Pages 6830-6839
Public URL https://durham-repository.worktribe.com/output/1607710